By targeting the DNA damage response (“DDR”) in cancer cells, Breakpoint Therapeutics aims to advance to clinical development first-in-class oncology drugs that interfere with DNA repair and replication stress tolerance
pathways. Our mission is to develop drugs that succeed and complement PARP inhibitors and facilitate the cure of therapy resistant cancers.
pathways. Our mission is to develop drugs that succeed and complement PARP inhibitors and facilitate the cure of therapy resistant cancers.
Location: Germany, Hamburg
Employees: 1-10
Founded date: 2019
Investors 1
| Date | Name | Website |
| - | Taiho Vent... | taihoventu... |
Mentions in press and media 2
| Date | Title | Description |
| 20.06.2023 | Biotech Breakthroughs: Unraveling Germany’s 15 Emerging Biotechnology Startups | Emergence Therapeutics led by Jack Elands, is a promising biopharmaceutical company dedicated to advancing novel ADC immunotherapies to address cancers with high unmet needs. Table of Contents show 1 FaCellitate – Supporting Drug Discover... |
| 09.10.2021 | Top 10 Healthcare Startups in Germany | The global healthcare market is expected to reach USD 11,908.9 billion by 2022, growing at a CAGR of 8.9%. Germany stands as the 3rd largest market for healthcare and medical products and is No. 1 in Europe, and the country’s healthcare ind... |